0
The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040 www.rootsanalysis.comban site
SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share
category news
posted by berry_cristan 1 year ago
0 comments
flag/unflag
delete
delete and ban this url
Comments (0)
You need to be logged in to write comments!
This story has no comments.